| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |